Intense Foxp3+CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+CD25+ ratio

British Journal of Dermatology

Volumn 172, Issue 1, 2015, Pages 64-73

  Azzimonti, B ^a   Zavattaro, E ^a   Provasi, M ^a   Vidali, M ^a   Conca, A ^a   Catalano, E ^a   Rimondini, L ^a   Colombo, E ^a   Valente, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CD8 FOXP3 CD25 RATIO; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOXP3+ CD25+ T LYMPHOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LYMPHOCYTE COUNT; MALE; MEDICAL RECORD REVIEW; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; T LYMPHOCYTE; VERY ELDERLY; CANCER GRADING; CELLULAR IMMUNITY; DENDRITIC CELL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; NEOPLASM GRADING; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84920845127     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13172     Document Type: Article

References (45)

1. Diepgen TL, Mahler V,. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (Suppl. 61): 1-6.
2. Staples MP, Elwood M, Burton RC, et al,. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
3. Warner CL, Cockerell CJ,. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol 2011; 12: 147-54.
4. Cassarino DS, Derienzo DP, Barr RJ,. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part two. J Cutan Pathol 2006; 33: 261-79.
5. Frierson HF Jr, Cooper PH,. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol 1986; 17: 346-54.
6. Petter G, Haustein UF,. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 2000; 26: 521-30.
7. Alam M, Ratner D,. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344: 975-83.
8. Rudolph R, Zelac DE,. Squamous cell carcinoma of the skin. Plast Reconstr Surg 2004; 114: 82e-94e.
9. Cassarino DS, Derienzo DP, Barr RJ,. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. J Cutan Pathol 2006; 33: 191-206.
10. Berg D, Otley CC,. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.
11. Smith KJ, Hamza S, Skelton H,. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004; 30: 634-41.
12. Euvrard S, Kanitakis J, Decullier E, et al,. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81: 1093-100.
13. Harwood CA, Surentheran T, Sasieni P, et al,. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150: 949-57.
14. Pfister H,. HPV and skin neoplasia. Hautarzt 2008; 59: 26-30. (in German).
15. Azzimonti B, Dell'Oste V, Borgogna C, et al,. The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. Virology 2009; 388: 260-9.
16. Ch'ng S, Clark JR, Brunner M, et al,. Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma. Head Neck 2013; 35: 190-4.
17. Facciabene A, Motz GT, Coukos G,. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res 2012; 72: 2162-71.
18. Hussein MR,. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 2005; 32: 191-205.
19. Schwarz A, Schwarz T,. UVR-induced regulatory T cells switch antigen-presenting cells from a stimulatory to a regulatory phenotype. J Invest Dermatol 2010; 130: 1914-21.
20. Reizis B, Colonna M, Trinchieri G, et al,. Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat Rev Immunol 2011; 11: 558-65.
21. Whiteside TL,. Anti-tumor vaccines in head and neck cancer: targeting immune responses to the tumor. Curr Cancer Drug Targets 2007; 7: 633-42.
22. Nishikawa H, Sakaguchi S,. Regulatory T cells in tumor immunity. Int J Cancer 2010; 127: 759-67.
23. Hartmann E, Wollenberg B, Rothenfusser S, et al,. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res 2003; 63: 6478-87.
24. Schuler PJ, Trellakis S, Greve J, et al,. In vitro chemosensitivity of head and neck cancer cell lines. Eur J Med Res 2010; 15: 337-44.
25. Thiel A, Kesselring R, Pries R, et al,. Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma. Oncol Rep 2011; 26: 615-20.
26. Chen CJ, Sung WW, Su TC, et al,. High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients. Clin Chim Acta 2013; 415: 25-30.
27. Viard-Leveugle I, Veyrenc S, French LE, et al,. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. J Pathol 2003; 201: 268-77.
28. Lewis MP, Lygoe KA, Nystrom ML, et al,. Tumor-derived TGF-β modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004; 90: 822-32.
29. high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 2006; 55: 1064-71.
30. Savage PA, Malchow S, Leventhal DS,. Basic principles of tumor-associated regulatory T cell biology. Trends Immunol 2013; 34: 33-40.
31. Sato E, Olson SH, Ahn J, et al,. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 18538-43.
32. Anz D, Eiber S, Scholz C, et al,. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype. Histopathology 2011; 59: 965-74.
33. Ladoire S, Martin F, Ghiringhelli F,. Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 2011; 60: 909-18.
34. Salama P, Platell C,. Colorectal cancer stem cells. ANZ J Surg 2009; 79: 697-702.
35. Mühleisen B, Petrov I, Gächter T, et al,. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate. Histopathology 2009; 55: 67-76.
36. Tallon B, Bhawan J,. FoxP3 expression is increased in cutaneous squamous cell carcinoma with perineural invasion. J Cutan Pathol 2010; 37: 1184-5.
37. Flammiger A, Weisbach L, Huland H, et al,. High tissue density of Foxp3+ T cells is associated with clinical outcome in prostate cancer. Eur J Cancer 2013; 49: 1273-9.
38. Mahmoud SM, Paish EC, Powe DG, et al,. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Breast Cancer Res Treat 2011; 127: 99-108.
39. Curiel TJ, Coukos G, Zou L, et al,. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-9.
40. Itakura E, Huang RR, Wen DR, et al,. IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. Mod Pathol 2011; 24: 801-9.
41. Massaguè J,. TGFβ in Cancer. Cell 2008; 134: 215-30.
42. Clark RA, Chong BF, Mirchandani N, et al,. A novel method for the isolation of skin resident T cells from normal and diseased human skin. J Invest Dermatol 2006; 126: 1059-70.
43. Johnson BD, Jing W, Orentas RJ,. CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma. J Immunother 2007; 30: 203-14.
44. Grauer OM, Nierkens S, Bennink E, et al,. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int J Cancer 2007; 121: 95-105.
45. Curtin JF, Candolfi M, Fakhouri TM, et al,. Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials. PLoS ONE 2008; 3: e1983.